We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Advance Pharmaceutical Gets 483 for Quality System Lapses
Advance Pharmaceutical Gets 483 for Quality System Lapses
April 1, 2013
An inability to implement and follow certain quality system procedures resulted in a Form 483 with 20 observations for OTC drug and dietary supplement manufacturer Advance Pharmaceutical, the FDA says.